Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Amyloid. 2020 Aug 18;28(1):24–29. doi: 10.1080/13506129.2020.1808783

Table 1.

Apparent kex at all ligand concentrations calculated based on the fits to the subunit exchange data from experiment 1, experiment 2, and the combined data.

Kinetic Stabilizer Concentration (μM) apparent kex, Experiment 1 (h−1) apparent kex, Experiment 2 (h−1) apparent kex, Combined Experiments (h−1)
Tafamidis 0 0.0142 0.0140 0.0140
1 0.0116 0.0115 0.0114
5 0.0046 0.005 0.0046
10 0.0020 0.0023 0.0020
20 0.0008 0.0009 0.0008
30 0.0004 0.0005 0.0004
AG10 0 0.0148 0.0164 0.0147
1 0.0114 0.0129 0.0114
5 0.0022 0.0037 0.0026
10 0.0005 0.0012 0.0007
20 0.0001 0.0004 0.0002
30 0.0001 0.0002 0.0001
Tolcapone 0 0.0153 0.0157 0.0152
1 0.0123 0.0127 0.0123
5 0.0044 0.005 0.0045
10 0.0017 0.0021 0.0018
20 0.0007 0.0008 0.0007
30 0.0004 0.0005 0.0004
Diflunisal 0 0.0156 0.0141 0.0155
1 0.0153 0.0139 0.0151
5 0.0142 0.0129 0.0139
10 0.0129 0.0118 0.0126
20 0.0109 0.0100 0.0104
30 0.0093 0.0086 0.0088